METHOD AND COMPOSITION FOR TREATING A SEROTONIN RECEPTOR-MEDIATED CONDITION
- 专利权人:
- Vanda Pharmaceuticals; Inc.
- 发明人:
- Wolfgang, Curt D.,Baroldi, Paolo,Polymeropoulos, Mihael H.
- 申请号：
- AU2017232054
- 公开号：
- AU2017232054A1
- 申请日:
- 2017.09.19
- 申请国别(地区):
- AU
- 年份:
- 2017
- 代理人:
- 摘要：
- #$%^&*AU2017232054A120171012.pdf#####ABSTRACT A method and composition for treating serotonin receptor-mediated conditions.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Fused heterocyclic compounds
- 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
- 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
- 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
- Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity
